# The remedē® System for the Treatment of Central Sleep Apnea in Daily Practice

> **NCT02577445** · — · TERMINATED · sponsor: **LivaNova** · enrollment: 31 (actual)

## Conditions studied

- Sleep Apnea
- Central Sleep Disordered Breathing

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02577445
- **Lead sponsor:** LivaNova
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-02
- **Primary completion:** 2016-10
- **Final completion:** 2016-10
- **Target enrollment:** 31 (ACTUAL)
- **Why stopped:** Commercial distribution of the remedē System stopped by LivaNova.
- **Last updated:** 2017-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02577445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02577445, "The remedē® System for the Treatment of Central Sleep Apnea in Daily Practice". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02577445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*